BioMedEcon Reports Three Times Higher Healthcare Costs Among Patients With Obsessive-Compulsive Disorder Compared To Patients With Depression
BioMedEcon Health Economics and Outcomes Research has just delivered an oral presentation summarizing the results of a pioneering study that compares healthcare costs of patients with obsessive-compulsive disorder (OCD) to those of patients with depression. This presentation was delivered at the 31st Annual Meeting of the Society of General and Internal Medicine (SGIM) held in Pittsburgh, Penn. Generic zithromax pills no prescription This study, which was funded by Jazz Pharmaceuticals, Inc., examined nine years (1997-2006) of health claims data among adults enrolled in the Florida Medicaid program who were either newly-diagnosed with "pure OCD" (OCD without the presence of bipolar disorder, psychoses or depression) or "pure depression" (depression without the presence of bipolar disorder, psychoses or OCD).
Patients with OCD were matched to those with depression on sex, race/ethnicity, medical illness severity, and age. Results showed that patients with newly-diagnosed OCD had three times higher healthcare costs than those with newly-diagnosed depression during the two years following their index diagnosis (median, two-year, per-patient healthcare costs were $25,666 versus $7,732, pBuy ultram without prescription | Buy diflucan pills | Buy amoxil without prescription
Tags: depression, health